Neuropace Stock Investor Sentiment
| NPCE Stock | USD 14.49 0.04 0.28% |
About 55% of Neuropace's shareholders are presently thinking to get in. The analysis of overall sentiment of trading Neuropace stock suggests that some investors are interested at this time. The current market sentiment, together with Neuropace's historical and current headlines, can help investors time the market. In addition, many technical investors use Neuropace stock news signals to limit their universe of possible portfolio assets.
Neuropace | Build AI portfolio with Neuropace Stock |
Neuropace Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Neuropace can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors may consider stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to consider selling stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Neuropace's Stock prices. Below is the latest headlines and news related to Neuropace Stock. Current markets are slightly bearish. About 51% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.
Neuropace Largest EPS Surprises
Earnings surprises can significantly impact Neuropace's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-08-12 | 2025-06-30 | -0.22 | -0.26 | -0.04 | 18 | ||
2024-08-13 | 2024-06-30 | -0.3 | -0.26 | 0.04 | 13 | ||
2021-11-10 | 2021-09-30 | -0.3 | -0.34 | -0.04 | 13 | ||
2025-03-03 | 2024-12-31 | -0.2233 | -0.18 | 0.0433 | 19 | ||
2023-05-04 | 2023-03-31 | -0.46 | -0.41 | 0.05 | 10 | ||
2024-11-12 | 2024-09-30 | -0.27 | -0.19 | 0.08 | 29 |
There is far too much social signal, news, headlines, and media speculation about Neuropace that are available to investors today. This information is accessible both publicly - through Neuropace's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuropace-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuropace news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuropace relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuropace's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuropace alpha.
Neuropace Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 3051 shares by Martha Morrell of Neuropace at 13.5 subject to Rule 16b-3 | 11/20/2025 |
2 | Disposition of 1338 shares by Martha Morrell of Neuropace at 16.66 subject to Rule 16b-3 | 12/03/2025 |
3 | Acquisition by Fischer Frank M of 1431 shares of Neuropace at 16.59 subject to Rule 16b-3 | 12/19/2025 |
4 | NeuroPace, Inc. Receives Consensus Recommendation of Moderate Buy from Analysts - MarketBeat | 12/22/2025 |
5 | Acquisition by Fischer Frank M of 2303 shares of Neuropace at 10.31 subject to Rule 16b-3 | 12/26/2025 |
6 | NeuroPace Investment Analysts Weekly Ratings Updates | 12/31/2025 |
7 | NeuroPace Has Debt But No Earnings Should You Worry | 01/09/2026 |
8 | NeuroPace, Inc. Given Average Recommendation of Moderate Buy by Brokerages - MarketBeat | 01/16/2026 |
9 | Disposition of 1430 shares by Martha Morrell of Neuropace at 12.56 subject to Rule 16b-3 | 01/21/2026 |
10 | Brokerages Set NeuroPace, Inc. PT at 18.50 | 01/23/2026 |
11 | NeuroPace stock price target raised to 20 from 19 at Leerink Partners By Investing.com - Investing.com South Africa | 02/02/2026 |
12 | NeuroPace, Inc. Receives Average Recommendation of Moderate Buy from Brokerages - MarketBeat | 02/10/2026 |
Complementary Tools for Neuropace Stock analysis
When running Neuropace's price analysis, check to measure Neuropace's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuropace is operating at the current time. Most of Neuropace's value examination focuses on studying past and present price action to predict the probability of Neuropace's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuropace's price. Additionally, you may evaluate how the addition of Neuropace to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |